A portable graphical link to your paper (QR code) is provided below. If the code is placed, for example, on a poster, your paper can be accessed through a mobile device's QR code reader.

Right click on the image below to save it to your device.

QR Code for 10.1101/2022.11.20.22282565

Safety, Tolerability, and Immunogenicity of PIKA-Adjuvanted Re-combinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine in Healthy Adults: Interim results of an open-label and randomised Phase 1 clinical trial.